US Stock MarketDetailed Quotes
SGHT Sight Sciences
- 5.280
- +0.140+2.72%
Close Apr 26 16:00 ET
- 5.280
- 0.0000.00%
Post 16:13 ET
262.66MMarket Cap-4631P/E (TTM)
5.330High5.070Low51.47KVolume5.130Open5.140Pre Close269.81KTurnover0.18%Turnover RatioLossP/E (Static)49.75MShares10.97052wk High2.18P/B153.39MFloat Cap1.04052wk Low--Dividend TTM29.05MShs Float42.570Historical High--Div YieldTTM5.06%Amplitude1.040Historical Low5.242Avg Price1Lot Size
About Sight Sciences Company
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Company Profile
SymbolSGHT
Company NameSight Sciences
Listing DateJul 15, 2021
Issue Price24.00
Founded2010
CEOMr. Paul Badawi
MarketNASDAQ
Employees214
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4040 Campbell Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-877-266-1144
Websitehttp://www.sightsciences.com
Company Executives
- Name
- Position
- Salary
- Paul Badawi
- Director, President and Chief Executive Officer
- 8.58M
- Alison Bauerlein
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- --
- Dr. David Badawi, M.D.
- Chief Technology Officer and Director
- --
- Jeremy B. Hayden
- Chief Legal Officer
- --
- Matthew Link
- Chief Commercial Officer
- --
- Sam Park
- Chief Operating Officer
- 1.35M
- Staffan Encrantz
- Chairman of the Board
- 44.14K
- Donald J. Zurbay
- Independent Director
- 362.32K
- Catherine Mazzacco
- Independent Director
- --
- Brenda Becker
- Independent Director
- --
- Dr. Tamara R. Fountain, M.D.
- Independent Director
- --
- Erica J. Rogers
- Independent Director
- 357.67K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg